Clinical effects of plasmapheresis in acute Guillain-Barré syndrome
- PMID: 3733414
- DOI: 10.1007/BF02340874
Clinical effects of plasmapheresis in acute Guillain-Barré syndrome
Abstract
5 consecutive cases of acute GBS were treated by plasmapheresis (PP). Clinical features and results of therapy have been compared with those of 10 consecutive acute GBS cases untreated by PP. PP treatment, applied early during the phase of deterioration, seemed to stop deficit progression, thus eliminating the stationary stage and triggering recovery immediately. Complete recovery seemed to occur comparatively faster than in the untreated group.
Similar articles
-
Plasmapheresis versus plasma perfusion in acute Guillain-Barré syndrome.ASAIO J. 1994 Jul-Sep;40(3):M638-42. doi: 10.1097/00002480-199407000-00076. ASAIO J. 1994. PMID: 8555592 Clinical Trial.
-
[Clinical and neurophysiologic study of Guillain Barré syndrome: results of therapy with plasmapheresis].Riv Neurol. 1991 Jan-Feb;61(1):39-45. Riv Neurol. 1991. PMID: 1857922 Italian.
-
Plasmapheresis and acute Guillain-Barré syndrome. The Guillain-Barré syndrome Study Group.Neurology. 1985 Aug;35(8):1096-104. Neurology. 1985. PMID: 4022342 Clinical Trial.
-
Guillain-Barré syndrome: clinical and therapeutic observations.Ann Neurol. 1990;27 Suppl:S13-6. doi: 10.1002/ana.410270705. Ann Neurol. 1990. PMID: 2194419 Review.
-
[Guillain-Barré syndrome and plasma exchange].Ann Med Interne (Paris). 1990;141(7):593-6. Ann Med Interne (Paris). 1990. PMID: 2085236 Review. French. No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Miscellaneous